Canopy Growth Corp $ 17.37 -4.35 (-20.03%)
Warning! GuruFocus has detected 2 Severe warning signs with CGC. Click here to check it out.
Avg Vol (1m):
Market Cap $:
Enterprise Value $:
Current and historical daily P/E ratio for CGC (Canopy Growthrp) from 2010 to May 29 2020. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The P/E ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the P/E ratio is positive. Also for stocks with the same P/E ratio, the one with faster growth business is more attractive. Canopy Growth stock (CGC) PE ratio as of May 29 2020 is 0. More Details
Canopy Growth PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Canopy Growth PE Ratio (TTM) Comparison
|Company||Market Cap(Mil)||PE Ratio (TTM)|
Industry Healthcare » Drug Manufacturers » Drug Manufacturers - Specialty & Generic NAICS : 325412 NAICS : 3741
Compare TSX:BHC XCNQ:CURA TSX:CRON XCNQ:GTII TSX:ACB XCNQ:TRUL TSX:APHA XCNQ:CL TSX:GUD TSX:CWEB NYSE:ZTS TSE:4502 XTER:MRK HKSE:03692 TSE:4523 SZSE:000661 TSE:4507 SZSE:000538 NSE:SUNPHARMA SZSE:300601
Address 1 Hershey Drive, Smiths Falls, ON, CAN, K7A 0A8
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.